Characterization of Humanized Antibodies Secreted by
Aspergillus niger
-
Published:2004-05
Issue:5
Volume:70
Page:2567-2576
-
ISSN:0099-2240
-
Container-title:Applied and Environmental Microbiology
-
language:en
-
Short-container-title:Appl Environ Microbiol
Author:
Ward Michael1, Lin Cherry1, Victoria Doreen C.1, Fox Bryan P.1, Fox Judith A.1, Wong David L.1, Meerman Hendrik J.1, Pucci Jeff P.1, Fong Robin B.1, Heng Meng H.1, Tsurushita Naoya2, Gieswein Christine2, Park Minha2, Wang Huaming1
Affiliation:
1. Genencor International, Inc., Palo Alto, California 94304 2. Protein Design Labs, Inc., Fremont, California 94555
Abstract
ABSTRACT
Two different humanized immunoglobulin G1(κ) antibodies and an Fab′ fragment were produced by
Aspergillus niger
. The antibodies were secreted into the culture supernatant. Both light and heavy chains were initially synthesized as fusion proteins with native glucoamylase. After antibody assembly, cleavage by
A. niger
KexB protease allowed the release of free antibody. Purification by hydrophobic charge induction chromatography proved effective at removing any antibody to which glucoamylase remained attached. Glycosylation at N297 in the Fc region of the heavy chain was observed, but this site was unoccupied on approximately 50% of the heavy chains. The glycan was of the high-mannose type, with some galactose present, and the size ranged from Hex
6
GlcNAc
2
to Hex
15
GlcNAc
2
. An aglycosyl mutant form of antibody was also produced. No significant difference between the glycosylated antibody produced by
Aspergillus
and that produced by mammalian cell cultures was observed in tests for affinity, avidity, pharmacokinetics, or antibody-dependent cellular cytotoxicity function.
Publisher
American Society for Microbiology
Subject
Ecology,Applied Microbiology and Biotechnology,Food Science,Biotechnology
Reference33 articles.
1. Ballance, D. J., F. P. Buxton, and G. Turner. 1983. Transformation of Aspergillus nidulans by the orotidine-5′-phosphate decarboxylase gene of Neurospora crassa. Biochem. Biophys. Res. Commun.112:284-289. 2. Campbell, E. I., S. E. Unkles, J. A. Macro, C. van den Hondel, R. Contreras, and J. R. Kinghorn. 1989. Improved transformation efficiency of Aspergillus niger using the homologous niaD gene for nitrate reductase. Curr. Genet.16:53-56. 3. Carter, P., R. F. Kelley, M. L. Rodrigues, B. Snedecor, M. Covarrubias, M. D. Velligan, W. L. T. Wong, A. M. Rowland, C. E. Kotts, M. E. Carver, M. Yang, J. H. Bourell, H. M. Shepard, and D. Henner. 1992. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Bio/Technology10:163-167. 4. Carter, P., L. Presta, C. M. Gorman, J. B. B. Ridgway, D. Henner, W. L. T. Wong, A. M. Rowland, C. Kotts, M. E. Carver, and H. M. Shepard. 1992. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA89:4285-4289. 5. Dorai, H., B. M. Mueller, R. A. Reisfeld, and S. D. Gillies. 1991. Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function. Hybridoma10:211-217.
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|